Skip to main content
Erschienen in: Acta Diabetologica 2/2019

09.11.2018 | Original Article

A 9 years comparison of weight loss, disappearance of obesity, and resolution of diabetes mellitus with biliointestinal bypass and with adjustable gastric banding: experience of a collaborative network

verfasst von: Antonio E. Pontiroli, Ahmed S. Zakaria, Giancarlo Micheletto, Chiara Osio, Alessandro Saibene, Franco Folli, On Behalf of the LAGB10 Group

Erschienen in: Acta Diabetologica | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Aims

Long-term comparisons between bariatric surgical techniques have been performed for gastric bypass (RYGB), sleeve gastrectomy (LSG), and biliopancreatic diversion (BPD) vs gastric banding (LAGB), but short-term studies (6 months–4 years) have only compared biliointestinal bypass (BIBP) and LAGB. The participating institutions regularly perform both BIBP and LAGB with a common protocol, and the aim of this retrospective study was to compare long-term effects of the two procedures on body weight, on clinical and metabolic variables, and on resolution of obesity and of diabetes.

Methods

All procedures performed between 01/01/1998 and 31/12/2005 were considered; 73 out of 91 patients undergoing BIBP, and 154 out of 249 patients undergoing LAGB were evaluable up to 9 years.

Results

BIBP was significantly more effective than LAGB in terms of weight loss and of resolution of obesity (BMI < 30 kg/m2), in terms of decrease of systolic blood pressure and of serum cholesterol, and similar in terms of resolution of diabetes. In addition, the effect of BIBP was stable, while the effect of LAGB decreased with time.

Conclusions

Both BIBP and LAGB exert long-term effects on body weight, on blood pressure, and on resolution of diabetes mellitus; the effect of BIBP is significantly greater than the effect of LAGB in terms of weight loss, resolution of obesity, of control of systolic blood pressure and of serum cholesterol, but not in terms of resolution of diabetes.
Literatur
1.
Zurück zum Zitat Amin PB, Weiner M (2010) Conversion of intestinal bypass to Roux-en-Y gastric bypass: a case report and brief review. Obes Surg 20:804–807CrossRefPubMed Amin PB, Weiner M (2010) Conversion of intestinal bypass to Roux-en-Y gastric bypass: a case report and brief review. Obes Surg 20:804–807CrossRefPubMed
2.
Zurück zum Zitat Ikramuddin S, Kellogg TA, Leslie DB (2007) Laparoscopic conversion of vertical banded gastroplasty to a Roux-en-Y gastric bypass. Surg Endosc 21:1927–1930CrossRefPubMed Ikramuddin S, Kellogg TA, Leslie DB (2007) Laparoscopic conversion of vertical banded gastroplasty to a Roux-en-Y gastric bypass. Surg Endosc 21:1927–1930CrossRefPubMed
3.
Zurück zum Zitat O’Brien PE, MacDonald L, Anderson M, Brennan L, Brown WA (2013) Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg 257:87–94CrossRefPubMed O’Brien PE, MacDonald L, Anderson M, Brennan L, Brown WA (2013) Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature. Ann Surg 257:87–94CrossRefPubMed
4.
Zurück zum Zitat Buchwald H, Oien DM (2013) Metabolic/bariatric surgery worldwide 2011. Obes Surg 23:427–436CrossRefPubMed Buchwald H, Oien DM (2013) Metabolic/bariatric surgery worldwide 2011. Obes Surg 23:427–436CrossRefPubMed
6.
Zurück zum Zitat Buchwald H, Estok R, Fahrbach K et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248–256CrossRefPubMed Buchwald H, Estok R, Fahrbach K et al (2009) Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 122:248–256CrossRefPubMed
7.
Zurück zum Zitat Eriksson F (1981) Biliointestinal bypass. Int J Obes 5:437–447PubMed Eriksson F (1981) Biliointestinal bypass. Int J Obes 5:437–447PubMed
8.
Zurück zum Zitat Doldi SB, Lattuada E, Zappa MA, Pieri G, Restelli A, Micheletto G (1998) Biliointestinal bypass: another surgical option. Obes Surg 8:566–569CrossRefPubMed Doldi SB, Lattuada E, Zappa MA, Pieri G, Restelli A, Micheletto G (1998) Biliointestinal bypass: another surgical option. Obes Surg 8:566–569CrossRefPubMed
9.
Zurück zum Zitat Del Genio G, Gagner M, Limongelli P et al (2016) Remission of type 2 diabetes in patients undergoing biliointestinal bypass for morbid obesity: a new surgical treatment. Surg Obes Relat Dis 12:815–821CrossRefPubMed Del Genio G, Gagner M, Limongelli P et al (2016) Remission of type 2 diabetes in patients undergoing biliointestinal bypass for morbid obesity: a new surgical treatment. Surg Obes Relat Dis 12:815–821CrossRefPubMed
10.
Zurück zum Zitat Dolan K, Hatzifotis M, Newbury L, Fielding G (2004) A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes Surg 14:165–169CrossRefPubMed Dolan K, Hatzifotis M, Newbury L, Fielding G (2004) A comparison of laparoscopic adjustable gastric banding and biliopancreatic diversion in superobesity. Obes Surg 14:165–169CrossRefPubMed
11.
Zurück zum Zitat Parikh M, Ayoung-Chee P, Romanos E et al (2007) Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. J Am Coll Surg 205:631–635CrossRefPubMed Parikh M, Ayoung-Chee P, Romanos E et al (2007) Comparison of rates of resolution of diabetes mellitus after gastric banding, gastric bypass, and biliopancreatic diversion. J Am Coll Surg 205:631–635CrossRefPubMed
12.
Zurück zum Zitat Nguyen NT, Slone JA, Nguyen XM, Hartman JS, Hoyt DB (2009) A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg 250:631–641PubMed Nguyen NT, Slone JA, Nguyen XM, Hartman JS, Hoyt DB (2009) A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs. Ann Surg 250:631–641PubMed
13.
Zurück zum Zitat Pontiroli AE, Laneri M, Veronelli A et al (2009) Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters. Cardiovasc Diabetol 8:37CrossRefPubMedPubMedCentral Pontiroli AE, Laneri M, Veronelli A et al (2009) Biliary pancreatic diversion and laparoscopic adjustable gastric banding in morbid obesity: their long-term effects on metabolic syndrome and on cardiovascular parameters. Cardiovasc Diabetol 8:37CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Padwal R, Klarenbach S, Wiebe N et al (2011) Bariatric surgery: a systematic review and network meta-analysis of randomized trials. Obes Rev 12:602–621CrossRefPubMed Padwal R, Klarenbach S, Wiebe N et al (2011) Bariatric surgery: a systematic review and network meta-analysis of randomized trials. Obes Rev 12:602–621CrossRefPubMed
15.
Zurück zum Zitat Chakravarty PD, McLaughlin E, Whittaker D et al (2012) Comparison of laparoscopic adjustable gastric banding (LAGB) with other bariatric procedures; a systematic review of the randomised controlled trials. Surgeon 10:172–182CrossRefPubMed Chakravarty PD, McLaughlin E, Whittaker D et al (2012) Comparison of laparoscopic adjustable gastric banding (LAGB) with other bariatric procedures; a systematic review of the randomised controlled trials. Surgeon 10:172–182CrossRefPubMed
16.
Zurück zum Zitat Angrisani L, Cutolo PP, Formisano G, Nosso G, Vitolo G (2013) Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 10-year results of a prospective, randomized trial. Surg Obes Relat Dis 9:405–413CrossRefPubMed Angrisani L, Cutolo PP, Formisano G, Nosso G, Vitolo G (2013) Laparoscopic adjustable gastric banding versus Roux-en-Y gastric bypass: 10-year results of a prospective, randomized trial. Surg Obes Relat Dis 9:405–413CrossRefPubMed
17.
Zurück zum Zitat Caiazzo R, Lassailly G, Leteurtre E et al (2014) Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg 260:893–898CrossRefPubMed Caiazzo R, Lassailly G, Leteurtre E et al (2014) Roux-en-Y gastric bypass versus adjustable gastric banding to reduce nonalcoholic fatty liver disease: a 5-year controlled longitudinal study. Ann Surg 260:893–898CrossRefPubMed
18.
Zurück zum Zitat Corradini SG, Eramo A, Lubrano C et al (2005) Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity. Obes Surg 15:367–377CrossRefPubMed Corradini SG, Eramo A, Lubrano C et al (2005) Comparison of changes in lipid profile after bilio-intestinal bypass and gastric banding in patients with morbid obesity. Obes Surg 15:367–377CrossRefPubMed
19.
Zurück zum Zitat Frige’ F, Laneri M, Veronelli A et al (2009) Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis 19:198–204CrossRefPubMed Frige’ F, Laneri M, Veronelli A et al (2009) Bariatric surgery in obesity: changes of glucose and lipid metabolism correlate with changes of fat mass. Nutr Metab Cardiovasc Dis 19:198–204CrossRefPubMed
20.
Zurück zum Zitat Benetti A, Del Puppo M, Crosignani A et al (2013) Cholesterol metabolism after bariatric surgery in grade 3 obesity. Differences between malabsorptive and restrictive procedures. Diabetes Care 36:1443–1447CrossRefPubMedPubMedCentral Benetti A, Del Puppo M, Crosignani A et al (2013) Cholesterol metabolism after bariatric surgery in grade 3 obesity. Differences between malabsorptive and restrictive procedures. Diabetes Care 36:1443–1447CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Lubrano C, Mariani S, Badiali M et al (2010) Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors. Int J Obes 34:1404–1414CrossRef Lubrano C, Mariani S, Badiali M et al (2010) Metabolic or bariatric surgery? Long-term effects of malabsorptive vs restrictive bariatric techniques on body composition and cardiometabolic risk factors. Int J Obes 34:1404–1414CrossRef
22.
Zurück zum Zitat Pontiroli AE, Gniuli D, Mingrone G (2010) Early effects of gastric banding (LGB) and of biliopancreatic diversion (BPD) on insulin sensitivity and on glucose and insulin response after OGTT. Obes Surg 20:474–479CrossRefPubMed Pontiroli AE, Gniuli D, Mingrone G (2010) Early effects of gastric banding (LGB) and of biliopancreatic diversion (BPD) on insulin sensitivity and on glucose and insulin response after OGTT. Obes Surg 20:474–479CrossRefPubMed
23.
Zurück zum Zitat Alam I, Stephens JW, Fielding A, Lewis KE, Lewis MJ, Baxter JN (2012) Temporal changes in glucose and insulin homeostasis after biliopancreatic diversion and laparoscopic adjustable gastric banding. Surg Obes Relat Dis 8:752–763CrossRefPubMed Alam I, Stephens JW, Fielding A, Lewis KE, Lewis MJ, Baxter JN (2012) Temporal changes in glucose and insulin homeostasis after biliopancreatic diversion and laparoscopic adjustable gastric banding. Surg Obes Relat Dis 8:752–763CrossRefPubMed
24.
Zurück zum Zitat Pontiroli AE, Zakaria AS, Mantegazza E et al (2016) Long-term mortality and incidence of cardiovascular diseases and type 2 diabetes in diabetic and nondiabetic obese patients undergoing gastric banding: a controlled study. Cardiovasc Diabetol 15:39CrossRefPubMedPubMedCentral Pontiroli AE, Zakaria AS, Mantegazza E et al (2016) Long-term mortality and incidence of cardiovascular diseases and type 2 diabetes in diabetic and nondiabetic obese patients undergoing gastric banding: a controlled study. Cardiovasc Diabetol 15:39CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Pontiroli AE, Pizzocri P, Librenti MC et al (2002) Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 87:3555–3561CrossRefPubMed Pontiroli AE, Pizzocri P, Librenti MC et al (2002) Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab 87:3555–3561CrossRefPubMed
27.
Zurück zum Zitat Vandenbroucke JP, von Elm E, Altman DG et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 4:e297CrossRefPubMedPubMedCentral Vandenbroucke JP, von Elm E, Altman DG et al (2007) Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration. PLoS Med 4:e297CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Suter M, Calmes JM, Paroz A, Giusti V (2006) A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates. Obes Surg 16:829–835CrossRefPubMed Suter M, Calmes JM, Paroz A, Giusti V (2006) A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates. Obes Surg 16:829–835CrossRefPubMed
29.
Zurück zum Zitat Tolonen P, Victorzon M, Mäkelä J (2008) 11-year experience with laparoscopic adjustable gastric banding for morbid obesity–what happened to the first 123 patients? Obes Surg 18:251–255CrossRefPubMed Tolonen P, Victorzon M, Mäkelä J (2008) 11-year experience with laparoscopic adjustable gastric banding for morbid obesity–what happened to the first 123 patients? Obes Surg 18:251–255CrossRefPubMed
30.
Zurück zum Zitat Spivak H, Abdelmelek MF, Beltran OR, Ng AW, Kitahama S (2012) Long-term outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in the United States. Surg Endosc 26:1909–1919CrossRefPubMed Spivak H, Abdelmelek MF, Beltran OR, Ng AW, Kitahama S (2012) Long-term outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in the United States. Surg Endosc 26:1909–1919CrossRefPubMed
31.
Zurück zum Zitat Zakaria AS, Rossetti L, Cristina M et al (2016) Effects of gastric banding on glucose tolerance, cardiovascular and renal function, and diabetic complications: a 13-year study of the morbidly obese. Surg Obes Relat Dis 12:587–595CrossRefPubMed Zakaria AS, Rossetti L, Cristina M et al (2016) Effects of gastric banding on glucose tolerance, cardiovascular and renal function, and diabetic complications: a 13-year study of the morbidly obese. Surg Obes Relat Dis 12:587–595CrossRefPubMed
32.
Zurück zum Zitat Pontiroli AE, Morabito A (2011) Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg 253:484–487CrossRefPubMed Pontiroli AE, Morabito A (2011) Long-term prevention of mortality in morbid obesity through bariatric surgery. A systematic review and meta-analysis of trials performed with gastric banding and gastric bypass. Ann Surg 253:484–487CrossRefPubMed
33.
Zurück zum Zitat Scicali R, Rosenbaum D, Di Pino A et al (2018) An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects. Acta Diabetol 55:741–749CrossRefPubMed Scicali R, Rosenbaum D, Di Pino A et al (2018) An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects. Acta Diabetol 55:741–749CrossRefPubMed
34.
Zurück zum Zitat Salehidoost R, Mansouri A, Amini M, Yamini SA, Aminorroaya A (2018) Body mass index and the all-cause mortality rate in patients with type 2 diabetes mellitus. Acta Diabetol 55:569–577CrossRefPubMed Salehidoost R, Mansouri A, Amini M, Yamini SA, Aminorroaya A (2018) Body mass index and the all-cause mortality rate in patients with type 2 diabetes mellitus. Acta Diabetol 55:569–577CrossRefPubMed
Metadaten
Titel
A 9 years comparison of weight loss, disappearance of obesity, and resolution of diabetes mellitus with biliointestinal bypass and with adjustable gastric banding: experience of a collaborative network
verfasst von
Antonio E. Pontiroli
Ahmed S. Zakaria
Giancarlo Micheletto
Chiara Osio
Alessandro Saibene
Franco Folli
On Behalf of the LAGB10 Group
Publikationsdatum
09.11.2018
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 2/2019
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1221-0

Weitere Artikel der Ausgabe 2/2019

Acta Diabetologica 2/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Triglyzeridsenker schützt nicht nur Hochrisikopatienten

10.05.2024 Hypercholesterinämie Nachrichten

Patienten mit Arteriosklerose-bedingten kardiovaskulären Erkrankungen, die trotz Statineinnahme zu hohe Triglyzeridspiegel haben, profitieren von einer Behandlung mit Icosapent-Ethyl, und zwar unabhängig vom individuellen Risikoprofil.

Gibt es eine Wende bei den bioresorbierbaren Gefäßstützen?

In den USA ist erstmals eine bioresorbierbare Gefäßstütze – auch Scaffold genannt – zur Rekanalisation infrapoplitealer Arterien bei schwerer PAVK zugelassen worden. Das markiert einen Wendepunkt in der Geschichte dieser speziellen Gefäßstützen.

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Wie managen Sie die schmerzhafte diabetische Polyneuropathie?

10.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Mit Capsaicin-Pflastern steht eine neue innovative Therapie bei schmerzhafter diabetischer Polyneuropathie zur Verfügung. Bei therapierefraktären Schmerzen stellt die Hochfrequenz-Rückenmarkstimulation eine adäquate Option dar.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.